{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:47:57Z","timestamp":1776397677064,"version":"3.51.2"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.idnow.2025.105103","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T11:27:40Z","timestamp":1748345260000},"page":"105103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Appropriateness of piperacillin-tazobactam prescriptions: a prospective multicentre study"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5954-5967","authenticated-orcid":false,"given":"Pierre-Marie","family":"Roger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Lechiche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Quint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agn\u00e8s","family":"Simand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Roghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Comparot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc-Antoine","family":"Hennet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Beranger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Mignonat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure","family":"Belmondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Denes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.idnow.2025.105103_b0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jama.2018.19509","article-title":"Rethinking how antibiotics are prescribed: incorporating the 4 moments of antibiotic decision making into clinical practice","volume":"321","author":"Tamma","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.idnow.2025.105103_b0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.53806","article-title":"Association between antimicrobial stewardship programs and antibiotic use globally: a systematic review and meta-analysis","volume":"6","author":"Zay Ya","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.idnow.2025.105103_b0015","unstructured":"European Centre for Disease Prevention and Control [Internet]. 2022. Antimicrobial Consumption in the EU\/EEA (ESAC-Net) \u2013 Annual Epidemiological Report for 2021 [cited September 24, 2023]. Available from: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/surveillance-antimicrobial-consumption-europe-2021."},{"key":"10.1016\/j.idnow.2025.105103_b0020","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3390\/antibiotics12071192","article-title":"Drug utilization evaluation and impact of pharmacist interventions on optimization of piperacillin\/ tazobactam use: a retrospective analysis and prospective audit","volume":"12","author":"Arain","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.idnow.2025.105103_b0025","unstructured":"Sant\u00e9 publique France [Internet]. Enqu\u00eate nationale de pr\u00e9valence 2022 des infections nosocomiales et des traitements anti-infectieux en \u00e9tablissements de sant\u00e9. Guide de l\u2019enqu\u00eateur. Mai - juin 2022 [cited August 4, 2023]. Available from: https:\/\/www.cpias-ile-de-france.fr\/surveillance\/enp\/2022\/SpF-ENP-2022-Guide-Enqueteur.pdf."},{"key":"10.1016\/j.idnow.2025.105103_b0030","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3390\/antibiotics13090837","article-title":"Impact of the COVID-19 pandemic on inpatient antibiotic and antifungal drug prescribing volumes in Germany","volume":"13","author":"Kern","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.idnow.2025.105103_b0035","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3390\/antibiotics13020180","article-title":"Antibiotic consumption 2017\u20132022 in 30 private hospitals in France: impact of antimicrobial stewardship tools and COVID-19 pandemic","volume":"13","author":"Roger","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.idnow.2025.105103_b0040","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ajic.2015.05.020","article-title":"Retrospective cohort study of inappropriate piperacillin-tazobactam use for lower respiratory tract and skin and soft tissue infections: opportunities for antimicrobial stewardship","volume":"43","author":"Havey","year":"2015","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.idnow.2025.105103_b0045","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10096-019-03490-6","article-title":"Adherence to antibiotic guidelines for erysipelas or cellulitis is associated with a favorable outcome","volume":"38","author":"Klotz","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.idnow.2025.105103_b0050","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/jpids\/piv036","article-title":"Piperacillin-tazobactam usage at a tertiary pediatric hospital: an antimicrobial stewardship review","volume":"5","author":"Janowski","year":"2016","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.idnow.2025.105103_b0055","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2442523","article-title":"A modelling framework to characterize the impact of antibiotics on the gut microbiota diversity","volume":"17","author":"Olivares","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.idnow.2025.105103_b0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.SLA.0000048551.32606.73","article-title":"Ertapenem versus piperacillin\/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial","volume":"237","author":"Solomkin","year":"2003","journal-title":"Ann Surg"},{"key":"10.1016\/j.idnow.2025.105103_b0065","article-title":"Efficacy of extended infusion of \u03b2-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients (BEATLE): a randomised, multicentre, open-label, superiority clinical trial","author":"Laporte-Amargos","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idnow.2025.105103_b0070","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00134-021-06609-6","article-title":"Effect of therapeutic drug monitoring-based dose optimization of piperacillin\/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial","volume":"48","author":"Hagel","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.idnow.2025.105103_b0075","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3390\/antibiotics11091144","article-title":"Clinical impact of a pharmacist-driven prospective audit with intervention and feedback on the treatment of patients with bloodstream infection","volume":"11","author":"Okada","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.idnow.2025.105103_b0080","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/00185787221139429","article-title":"Pilot study: impact of a pharmacist-led 48-hour antibiotic time-out on antibiotic utilization and outcome measures in a community teaching hospital","volume":"58","author":"Chikeka","year":"2023","journal-title":"Hosp Pharm"},{"key":"10.1016\/j.idnow.2025.105103_b0085","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/cid\/ciy921","article-title":"Risk factors for unnecessary antibiotic therapy: a major role for clinical management","volume":"69","author":"Roger","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2025.105103_b0090","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/jac\/dkae401","article-title":"Diagnostic uncertainties in patients with bacteraemia: impact on antibiotic prescriptions and outcome","volume":"80","author":"Roger","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idnow.2025.105103_b0095","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000513742","article-title":"Nephrotoxicity from vancomycin combined with piperacillin-tazobactam: a comprehensive review","volume":"52","author":"Blair","year":"2021","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.idnow.2025.105103_b0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s13054-021-03660-z","article-title":"Impact of a restrictive antibiotic policy on the acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae in an endemic region: a before-and-after, propensity-matched cohort study in a Caribbean intensive care unit","volume":"25","author":"Le Terrier","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.idnow.2025.105103_b0105","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1469-0691.2009.02920.x","article-title":"Easily available adjustment criteria for the comparison of antibiotic consumption in a hospital setting: experience in France","volume":"16","author":"Amadeo","year":"2010","journal-title":"Clin Microbiol Infect"}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266699192500082X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266699192500082X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T02:10:26Z","timestamp":1756865426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266699192500082X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S266699192500082X"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2025.105103","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Appropriateness of piperacillin-tazobactam prescriptions: a prospective multicentre study","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2025.105103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105103"}}